Figure S7 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
Year: 2025
Type: other
Abstract: MYLK-AS1 interacts with ILF3 to regulate TKI resistance in HCC827/GR and PC9/OR.
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4413469718
